Email updates

Keep up to date with the latest news and content from Breast Cancer Research and BioMed Central.

Correction

Correction: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer

Jisun Kim1, Wonshik Han12*, Hyeong-Gon Moon1, Soo K Ahn1, Hee-Chul Shin3, Jee-Man You4, Sae-Won Han5, Seock-Ah Im5, Tae-You Kim5, Hye R Koo6, Jung M Chang6, Nariya Cho6, Woo K Moon6 and Dong-Young Noh12

Author Affiliations

1 Department of Surgery, Seoul National University College of Medicine, 101 Daehakro, Seoul, 110-744, Korea

2 Cancer Research Institute, Seoul National University, 101 Daehakro, Seoul, 110-744, Korea

3 Department of Surgery, Chung-Ang University College of Medicine, 102 Heuksukro, Seoul, 156-755, Korea

4 Department of Surgery, Sun General Hospital, 29 Mokjungro, Daejeon, 301-725, Korea

5 Department of Internal Medicine, Seoul National University College of Medicine, 101 Daehakro, Seoul, 110-744, Korea

6 Department of Radiology, Seoul National University College of Medicine, 101 Daehakro, Seoul, 110-744, Korea

For all author emails, please log on.

Breast Cancer Research 2012, 14:403  doi:10.1186/bcr3353


See related research by Kim et al., http://breast-cancer-research.com/content/14/4/R102

The electronic version of this article is the complete one and can be found online at: http://breast-cancer-research.com/content/14/6/403


Published:19 November 2012

© 2012 BioMed Central Ltd

Correction

After publication of their article [1], the authors noted an error under the section "Density change and recurrence-free survival". Where it currently reads "After adjusting for confounding factors, patients with MDRR ≥ 15% had a higher risk of recurrence than patients with MDRR <15% (HR 1.60, 95% CI 1.02 to 2.50, P = 0.041) (Additional file 1, Table S5)", this should be changed to "After adjusting for confounding factors, patients with MDRR <15% had a higher risk of recurrence than patients with MDRR ≥ 15% (HR 1.60, 95% CI 1.02 to 2.50, P = 0.041) (Additional file 1, Table S5)."

Competing interests

The authors declare that they have no competing interests.

References

  1. Kim J, Han W, Moon HG, Ahn SK, Shin HC, You JM, Han SW, Im SA, Kim TY, Koo HR, Chang JM, Cho N, Moon WK, Noh DY: Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer.

    Breast Cancer Research 2012, 14:R102. PubMed Abstract | BioMed Central Full Text OpenURL